H

Helixmith Co Ltd
KOSDAQ:084990

Watchlist Manager
Helixmith Co Ltd
KOSDAQ:084990
Watchlist
Price: 5 950 KRW Market Closed
Market Cap: 274.2B KRW

Helixmith Co Ltd
Investor Relations

Helixmith Co., Ltd. engages in the development and sale of bio and natural substances. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-29. The firm operates its business through two segments. The Natural Products Business segment develops and sells raw materials for functional materials and health functional foods such as Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment develops diabetic neuropathy treatment, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis treatment, ischemic heart disease, and anticancer treatment.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Sunyoung Kim D.Phil., Ph.D.
Founder, CEO & Director
No Bio Available
Won Ho Park
Pres
No Bio Available
Mr. Michael Na
CFO & Director of Office of Strategic Net Assessment
No Bio Available
Mr. Seung-Shin Yu Ph.D.
CTO , Representative Director, MD of R&D Center and Intellectual Property & Director
No Bio Available
Jun Tae Park Ph.D.
Exec. VP of Licensing & Regulatory Affairs
No Bio Available
Miwon Son Ph.D.
Sr. Managing Director of Phytotherapeutics
No Bio Available
William O. Frank
Head of Medical
No Bio Available
Jong-Mook Kim Ph.D.
Director of Devel. Division & Strategic Bus. Division and Director
No Bio Available

Contacts

Address
SEOUL
Seoul
21, Magokjungang 8-ro 7-gil, Gangseo-gu
Contacts
+82221027200
helixmith.com